Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/87390
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKorse, C.-
dc.contributor.authorTaal, B.-
dc.contributor.authorVincent, A.-
dc.contributor.authorvan Velthuysen, M.-
dc.contributor.authorBaas, P.-
dc.contributor.authorBuning-Kager, J.-
dc.contributor.authorLinders, T.-
dc.contributor.authorBonfrer, J.-
dc.date.issued2012-
dc.identifier.citationEuropean Journal of Cancer, 2012; 48(5):662-671-
dc.identifier.issn0959-8049-
dc.identifier.issn1879-0852-
dc.identifier.urihttp://hdl.handle.net/2440/87390-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityCatharina M. Korse, Babs G. Taal, Andrew Vincent, Marie-Louise F. van Velthuysen, Paul Baas, Johanna C.G.M. Buning-Kager, Theodora C. Linders, Johannes M.G. Bonfrer-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2011 Elsevier Ltd. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/j.ejca.2011.08.012-
dc.subjectNeuroendocrine tumours; Chromogranin A; NSE; ProGRP; Cytokeratins; MonoTotal-
dc.titleChoice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments-
dc.typeJournal article-
dc.identifier.doi10.1016/j.ejca.2011.08.012-
pubs.publication-statusPublished-
dc.identifier.orcidVincent, A. [0000-0002-6428-1070]-
Appears in Collections:Aurora harvest 2
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.